跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZINC SULFATE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZINC SULFATE INJECTION, USP
Authorized
STANDARD
ZINC SULFATE INJECTION, USP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1568c6b9c3d12d26
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
1568c6b9c3d12d26
Drug Approval Canada Name
ZINC SULFATE INJECTION, USP
Product Name
ZINC SULFATE INJECTION, USP
Status
Marketed
Status Date
2023-09-08
Original Market Date
2023-09-08
Din
02532980
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05XA18 ZINC SULFATE
Atc Name
b 05 xa 18
Aig Number
0109299013
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ZINC (ZINC SULFATE)
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1568c6b9c3d12d26
Type
Standard
Back to Health Canada Approvals